BIT
CDTX

BlackRock Institutional Trust’s Cidara Therapeutics CDTX Stock Holding History

BlackRock Institutional Trust’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.02M Buy
4,906
+1,110
+29% +$231K ﹤0.01% 3290
2016
Q3 		$869K Buy
3,796
+183
+5% +$42.3K ﹤0.01% 3344
2016
Q2 		$745K Buy
3,613
+1,892
+110% +$458K ﹤0.01% 3406
2016
Q1 		$437K Sell
1,721
-69
-4% -$15.9K ﹤0.01% 3481
2015
Q4 		$614K Buy
1,790
+97
+6% +$29.1K ﹤0.01% 3459
2015
Q3 		$431K Buy
1,693
+224
+15% +$64K ﹤0.01% 3526
2015
Q2 		$412K Buy
+1,469
New +$452K ﹤0.01% 3539

Other funds holding CDTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Institutional Trust's CDTX Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Cidara Therapeutics (CDTX) stake by 29% in Q4 2016, buying an estimated $231K and bringing the position to 4,906 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #3290.

BlackRock Institutional Trust first reported a position in CDTX in Q2 2015 and has held it in 7 quarters since. 58 funds tracked by Wall St. Rank hold CDTX as of Q4 2016.

  • BlackRock Institutional Trust held 4,906 shares of Cidara Therapeutics worth $1.02M as of Q4 2016.
  • BlackRock Institutional Trust bought 1,110 Cidara Therapeutics shares in Q4 2016, an estimated $231K.
  • Cidara Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3290 holding.
  • BlackRock Institutional Trust first reported a position in Cidara Therapeutics in Q2 2015 and has held it in 7 quarters since.
  • 58 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.